Form 8-K - Current report:
SEC Accession No. 0002008861-24-000023
Filing Date
2024-10-21
Accepted
2024-10-21 09:29:08
Documents
13
Period of Report
2024-10-21
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ndoi-20241021.htm   iXBRL 8-K 37348
  Complete submission text file 0002008861-24-000023.txt   153944

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT ndoi-20241021.xsd EX-101.SCH 1845
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT ndoi-20241021_lab.xml EX-101.LAB 19410
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT ndoi-20241021_pre.xml EX-101.PRE 11035
15 EXTRACTED XBRL INSTANCE DOCUMENT ndoi-20241021_htm.xml XML 2517
Mailing Address 1400 ATWATER DRIVE MALVERN PA 19355
Business Address 1400 ATWATER DRIVE MALVERN PA 19355 (484) 216-0000
Endo, Inc. (Filer) CIK: 0002008861 (see all company filings)

EIN.: 301390281 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 333-280767 | Film No.: 241382183
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)